Diabetic Complications and Genetic Variants in the Million Veterans Program
百万退伍军人计划中的糖尿病并发症和遗传变异
基本信息
- 批准号:10368695
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdolescentAdultAgeBlood PressureBody mass indexCaringCharacteristicsClinicalComplications of Diabetes MellitusConsensusDNADataDevelopmentDiabetes MellitusDiabetic KetoacidosisDiagnosisDiseaseEFRACEmergency SituationEpigenetic ProcessEthnic OriginEye diseasesGene ExpressionGenesGeneticGenetic LoadGenetic RiskGenetic studyGenomeGlycosylated hemoglobin AGoalsHealthHeart failureHypoglycemiaIndividualInsulinInsulin-Dependent Diabetes MellitusKidney DiseasesLeadLibrariesLife StyleLiteratureMediatingMediationMendelian randomizationMethodsMethylationModelingModificationMolecularMorbidity - disease rateMutationNatural HistoryNon-Insulin-Dependent Diabetes MellitusOutcomeOutpatientsParticipantPathway interactionsPatternPersonsPhenotypePhysiologicalProcessPrognosisProteinuriaRaceReportingRetinal DiseasesRiskRisk FactorsSiteSystemTestingThromboplastinTimeTranslationsVeteransVisitbaseclinical riskclinical translationcomorbiditycostdemographicsdiabeticepigenome-wide association studiesepigenomicsgene environment interactiongenetic disorder diagnosisgenetic variantgenome wide association studygenome-widegenomic locusimprovedinsulin dependent diabetes mellitus onsetmacrovascular diseasemilitary servicemortalitymulti-ethnicmultiple omicsnon-geneticnovel therapeuticspersonalized carepersonalized medicinephenomicspolygenic risk scoreprecision medicinepredictive modelingpredictive testpreservationprogramsstatisticstrait
项目摘要
Diabetes (DM) complications are the major cause of its morbidity, mortality, and costs. MVP009 has
advanced understanding of the underlying genetics. Since DM care does not take advantage of progress in
genetics, we propose to use genetics to support both clinical translation and mechanistic discovery.
In MVP009, we utilized highly specific phenotypes in genome-wide association studies (GWAS) of
(i) heart failure (HF) with preserved vs. reduced ejection fraction; (ii) hypoglycemia – severe (emergency visits)
and incidental (outpatient visits); (iii) kidney disease; and (iv) eye disease. We also found that although typical,
“juvenile-onset type 1 diabetes (T1D)” excludes military service, at least 10% of Veterans with presumed T2D
in MVP may have “adult onset T1D” – largely unrecognized. We now propose to extend these findings.
Consistent with the Precision Medicine in Diabetes Consensus Report, our Aims target precision in
(i) diagnosis (genetic T1D vs. T2D), (ii) treatment [combining genetic with traditional risk factors (RF)], and (iii)
prognosis (epigenomic contributions to complications) – to incorporate genetics so that care can be more
accurate and individualized, and identify mechanisms that can lead to discovery of new treatments.
Aim 1: Assess the contributions of T1D and T2D genetic loads to the clinical characteristics
and disease trajectories of people presumed to have T2D. We will model multiethnic genetic risk with T1D
and T2D polygenic risk scores (PRS, with multiethnic data from large recent studies); each MVP Veteran will
have both a T1D and a T2D PRS. Outcomes will include incident DM, and the disease trajectory: age and BMI
at onset, time to insulin Rx, and ketoacidosis and hypoglycemia. We will evaluate the utility of the PRS to
identify Veterans with DM who would benefit from definitive T1D testing and/or early use of insulin.
Aim 2: Assess the combined contributions of genetic/nongenetic RF to development of
complications. (SubAim a) Identify effect modifications between RF and complications. Genetic
interaction analyses will include lifestyle, demographics, and comorbidities (e.g., blood pressure, HbA1c), as
modifiers of the risk of complications conferred by disease loci and PRS. We will use both hypothesis-testing
approaches for known loci and PRS, and hypothesis-generating approaches (using genome-wide G×E
modeling) to examine interactions associated with diabetic eye disease (DED), kidney disease (DKD), HF, and
hypoglycemia, and causal associations using state-of-the-art Mendelian Randomization (MR), including
multivariable and mediation MR. (SubAim b) Develop and test predictive models. We will use summary
statistics from the MVP GWAS and the literature, to develop separate PRS using the “best practice” recent
method, for DED, DKD, HF, and hypoglycemia, and PheWAS with the PRSs to elucidate previously unknown
RFs. Utilizing the PRS, PheWAS, information from SubAim (a), clinical RF, and treatments, we will develop
genome-informed predictive models that will be evaluated in eMERGE and more recent MVP participants.
Aim 3: Identify epigenomic markers and molecular systems underlying DM complications.
Epigenomic changes regulate gene expression, can mediate environmental and physiologic effects, and have
been associated with T2D and related glycemic traits. We hypothesize that differential methylation will also be
associated with DM complications. Methylation information using the EPIC chip (>850,000 sites) will be
available on >30,000 Veterans, and can be imputed in other Veterans, allowing epigenomic and multi-omic
methods such as aggregation analysis and epigenome-wide association studies to (i) identify associations with
the complications of DM as well as hypoglycemia, and (ii) identify the genes and pathways involved.
Impact: The genetics of diagnosis, G×E, epigenomics, and predictive models should both aid
translation – to identify risk in individuals, and help personalize treatment to reduce DM complications and
hypoglycemia – and support discovery of new therapies to mitigate the underlying processes.
糖尿病(DM)并发症是其发病率、死亡率和费用的主要原因。MVP009有
对潜在的遗传学有深入的了解。由于糖尿病护理没有利用在
遗传学,我们建议使用遗传学来支持临床翻译和机械发现。
在MVP009中,我们在全基因组关联研究中利用了高度特异的表型。
(I)射血分数保留或减少的心力衰竭(HF);(Ii)低血糖--严重(急诊)
(3)肾脏疾病;(4)眼科疾病。我们还发现,尽管是典型的,
“青少年起病的1型糖尿病(T1D)”不包括服兵役,至少10%的退伍军人被认为患有T2D
MVP中可能有“成人起病的T1D”--很大程度上无法识别。我们现在建议扩大这些研究结果。
与糖尿病中的精准医学共识报告一致,我们的目标是在
(一)诊断(遗传T1D与T2D),(二)治疗[结合遗传和传统风险因素(RF)],和(三)
预后(表观基因组对并发症的贡献)--结合遗传学,以便提供更多的护理
准确和个性化,并确定可能导致新治疗方法发现的机制。
目的1:评估T1D和T2D基因负荷对临床特征的影响
以及推定患有T2D的人的疾病轨迹。我们将用T1D对多种族遗传风险进行建模
和T2D多基因风险评分(PR,来自最近大型研究的多种族数据);每个MVP老将
既有T1D也有T2D PR。结果将包括糖尿病事件和疾病轨迹:年龄和BMI
发病时出现胰岛素Rx、酮症酸中毒和低血糖。我们会评估该计划的效用,以
确定患有糖尿病的退伍军人,他们将从明确的T1D测试和/或早期使用胰岛素中受益。
目的2:评估遗传性/非遗传性RF对糖尿病发展的综合贡献
并发症。(SubAim A)确定RF和并发症之间的影响修正。遗传
交互分析将包括生活方式、人口统计和共病(例如,血压、糖化血红蛋白),如
疾病位点和PR带来的并发症风险的修饰物。我们将使用这两种假设检验
已知基因座和PR的方法,以及假设生成方法(使用全基因组G×E
建模)以检查与糖尿病眼病(DED)、肾脏疾病(DKD)、心力衰竭和
低血糖和使用最先进的孟德尔随机化(MR)的因果联系,包括
多变量和中介先生(SubAim B)开发和测试预测模型。我们将使用摘要
来自MVP GWAS的统计数据和文献,以使用最近的“最佳实践”开发单独的PR
方法,用于DED、DKD、HF和低血糖,并用PRSS来阐明以前未知的
RFS。利用PRS、Phewas、来自SubAim(A)的信息、临床RF和治疗,我们将开发
基因组信息预测模型将在Emerge和更新的MVP参与者中进行评估。
目的3:确定糖尿病并发症的表观基因组标记和分子系统。
表观基因组变化调节基因表达,可以调节环境和生理效应,并具有
与T2D和相关的血糖特征有关。我们假设差异甲基化也将是
与糖尿病并发症相关。使用EPIC芯片(850,000个位点)的甲基化信息将是
适用于30,000名退伍军人,并可归因于其他退伍军人,允许表观基因组和多基因组
方法,如聚集分析和表观基因组范围的关联研究,以(I)确定与
糖尿病的并发症以及低血糖,以及(Ii)确定涉及的基因和途径。
影响:诊断遗传学、G×E、表观基因组学和预测模型都应该有所帮助
识别个体风险,并帮助个性化治疗以减少糖尿病并发症和
低血糖-并支持发现新的治疗方法来缓解潜在的过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE S PHILLIPS其他文献
LAWRENCE S PHILLIPS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE S PHILLIPS', 18)}}的其他基金
Diabetic Complications and Genetic Variants in the Million Veterans Program
百万退伍军人计划中的糖尿病并发症和遗传变异
- 批准号:
10655281 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Assessing Barriers and Facilitators for Participating Structured Lifestyle Intervention and its Real-world Effectiveness and Cost-Effectiveness among US Veterans
评估美国退伍军人参与结构化生活方式干预的障碍和促进因素及其现实世界的有效性和成本效益
- 批准号:
10554732 - 财政年份:2022
- 资助金额:
-- - 项目类别:
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES – “CHANGE” STUDY
改变 2 型糖尿病的自然病史 — — — 变化 — 研究
- 批准号:
10437877 - 财政年份:2021
- 资助金额:
-- - 项目类别:
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES – “CHANGE” STUDY
改变 2 型糖尿病的自然病史 — — — 变化 — 研究
- 批准号:
10619451 - 财政年份:2021
- 资助金额:
-- - 项目类别:
CHANGING THE NATURAL HISTORY OF TYPE 2 DIABETES – “CHANGE” STUDY
改变 2 型糖尿病的自然病史 — — — 变化 — 研究
- 批准号:
10298826 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Diabetic Complications and Genetic Variants in the Million Veterans Program
百万退伍军人计划中的糖尿病并发症和遗传变异
- 批准号:
9483196 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Diabetic Complications and Genetic Variants in the Million Veterans Program
百万退伍军人计划中的糖尿病并发症和遗传变异
- 批准号:
10908985 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Diabetic Complications and Genetic Variants in the Million Veterans Program
百万退伍军人计划中的糖尿病并发症和遗传变异
- 批准号:
10439613 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Diabetic Complications and Genetic Variants in the Million Veterans Program
百万退伍军人计划中的糖尿病并发症和遗传变异
- 批准号:
10268156 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Reach, Outcomes and System Impacts of the VA's National Weight Loss Program, MOVE
退伍军人管理局国家减肥计划 MOVE 的范围、成果和系统影响
- 批准号:
8878249 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似海外基金
Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening among Rural Screening Age-Eligible Adults
制定年轻人介导的干预措施,以增加农村符合筛查年龄的成年人的结直肠癌筛查
- 批准号:
10653464 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Doctoral Dissertation Research: Estimating adult age-at-death from the pelvis
博士论文研究:从骨盆估算成人死亡年龄
- 批准号:
2316108 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
Determining age dependent factors driving COVID-19 disease severity using experimental human paediatric and adult models of SARS-CoV-2 infection
使用 SARS-CoV-2 感染的实验性人类儿童和成人模型确定导致 COVID-19 疾病严重程度的年龄依赖因素
- 批准号:
BB/V006738/1 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Research Grant
Transplantation of Adult, Tissue-Specific RPE Stem Cells for Non-exudative Age-related macular degeneration (AMD)
成人组织特异性 RPE 干细胞移植治疗非渗出性年龄相关性黄斑变性 (AMD)
- 批准号:
10294664 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Sex differences in the effect of age on episodic memory-related brain function across the adult lifespan
年龄对成人一生中情景记忆相关脑功能影响的性别差异
- 批准号:
422882 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Operating Grants
Modelling Age- and Sex-related Changes in Gait Coordination Strategies in a Healthy Adult Population Using Principal Component Analysis
使用主成分分析对健康成年人群步态协调策略中与年龄和性别相关的变化进行建模
- 批准号:
430871 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Studentship Programs
Transplantation of Adult, Tissue-Specific RPE Stem Cells as Therapy for Non-exudative Age-Related Macular Degeneration AMD
成人组织特异性 RPE 干细胞移植治疗非渗出性年龄相关性黄斑变性 AMD
- 批准号:
9811094 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Doctoral Dissertation Research: Literacy Effects on Language Acquisition and Sentence Processing in Adult L1 and School-Age Heritage Speakers of Spanish
博士论文研究:识字对西班牙语成人母语和学龄传统使用者语言习得和句子处理的影响
- 批准号:
1823881 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Standard Grant
Adult Age-differences in Auditory Selective Attention: The Interplay of Norepinephrine and Rhythmic Neural Activity
成人听觉选择性注意的年龄差异:去甲肾上腺素与节律神经活动的相互作用
- 批准号:
369385245 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Research Grants